Immunohistochemical evaluation of MUC1 mucin expression in non-small cell lung cancers

Hiroshi Hashimoto; Hiroto Takahashi; Motoyasu Sagawa; Masami Sato; Chiaki Endo; Akira Sakurada; Hirokazu Aikawa; Nobuyuki Sato; Yasuki Saito; Shigefumi Fujimura

doi:10.2482/haigan.40.85

Immunohistochemical evaluation of MUC1 mucin expression in non-small cell lung cancers

Hiroshi Hashimoto, Hiroto Takahashi, Motoyasu Sagawa, Masami Sato, Chiaki Endo, Akira Sakurada, Hirokazu Aikawa, Nobuyuki Sato, Yasuki Saito, Shigefumi Fujimura

Research output: Contribution to journal › Article › peer-review

Abstract

We investigated the immunohistochemical expression of carcinoma- associated MUC1 in human lung cancer tissues using the monoclonal antibody MUSE11. We also investigated the expression of sialyl-Lewis x (sLe(x)) using monoclonal antibody FH-6. According to the histological type of lung cancer, MUSE11 positivity was observed in 90% of patients with adenocarcinoma (72/80), 51.6% of patients with squamous cell carcinoma (49/95), and 54.5% of patients with large cell carcinoma (12/22). A significant difference was detected in the expression of MUSE11 between adenocarcinoma and the two other histological types. Thus, MUSE11 appears to be a candidate for a tumor- associated marker in patients with lung adenocarcinoma. There was no relationship between the expression of MUSE11 and T factors, N factors, pathological stage, grade of differentiation, or prognosis. A significant relationship was detected between the expression of MUSE11 and that of FH-6. Earlier studies have revealed that part of sLe is associated with the MUC1 polypeptide. Our results suggested that the relationship also existed in human lung cancer specimens.

Original language	English
Pages (from-to)	85-91
Number of pages	7
Journal	Japanese Journal of Lung Cancer
Volume	40
Issue number	2
DOIs	https://doi.org/10.2482/haigan.40.85
Publication status	Published - 2000 Apr

Keywords

FH-6
Immunohistochemistry
Lung cancer
MUC1
MUSE11

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.2482/haigan.40.85

Fingerprint Dive into the research topics of 'Immunohistochemical evaluation of MUC1 mucin expression in non-small cell lung cancers'. Together they form a unique fingerprint.

Cite this

Immunohistochemical evaluation of MUC1 mucin expression in non-small cell lung cancers. / Hashimoto, Hiroshi; Takahashi, Hiroto; Sagawa, Motoyasu; Sato, Masami; Endo, Chiaki; Sakurada, Akira; Aikawa, Hirokazu; Sato, Nobuyuki; Saito, Yasuki; Fujimura, Shigefumi.

In: Japanese Journal of Lung Cancer, Vol. 40, No. 2, 04.2000, p. 85-91.

Research output: Contribution to journal › Article › peer-review

@article{e3dacc8f40f645319685a7f8b3fd6f55,

title = "Immunohistochemical evaluation of MUC1 mucin expression in non-small cell lung cancers",

abstract = "We investigated the immunohistochemical expression of carcinoma- associated MUC1 in human lung cancer tissues using the monoclonal antibody MUSE11. We also investigated the expression of sialyl-Lewis x (sLe(x)) using monoclonal antibody FH-6. According to the histological type of lung cancer, MUSE11 positivity was observed in 90% of patients with adenocarcinoma (72/80), 51.6% of patients with squamous cell carcinoma (49/95), and 54.5% of patients with large cell carcinoma (12/22). A significant difference was detected in the expression of MUSE11 between adenocarcinoma and the two other histological types. Thus, MUSE11 appears to be a candidate for a tumor- associated marker in patients with lung adenocarcinoma. There was no relationship between the expression of MUSE11 and T factors, N factors, pathological stage, grade of differentiation, or prognosis. A significant relationship was detected between the expression of MUSE11 and that of FH-6. Earlier studies have revealed that part of sLe is associated with the MUC1 polypeptide. Our results suggested that the relationship also existed in human lung cancer specimens.",

keywords = "FH-6, Immunohistochemistry, Lung cancer, MUC1, MUSE11",

author = "Hiroshi Hashimoto and Hiroto Takahashi and Motoyasu Sagawa and Masami Sato and Chiaki Endo and Akira Sakurada and Hirokazu Aikawa and Nobuyuki Sato and Yasuki Saito and Shigefumi Fujimura",

year = "2000",

month = apr,

doi = "10.2482/haigan.40.85",

language = "English",

volume = "40",

pages = "85--91",

journal = "Japanese Journal of Lung Cancer",

issn = "0386-9628",

publisher = "Japan Lung Cancer Society",

number = "2",

}

TY - JOUR

T1 - Immunohistochemical evaluation of MUC1 mucin expression in non-small cell lung cancers

AU - Hashimoto, Hiroshi

AU - Takahashi, Hiroto

AU - Sagawa, Motoyasu

AU - Sato, Masami

AU - Endo, Chiaki

AU - Sakurada, Akira

AU - Aikawa, Hirokazu

AU - Sato, Nobuyuki

AU - Saito, Yasuki

AU - Fujimura, Shigefumi

PY - 2000/4

Y1 - 2000/4

N2 - We investigated the immunohistochemical expression of carcinoma- associated MUC1 in human lung cancer tissues using the monoclonal antibody MUSE11. We also investigated the expression of sialyl-Lewis x (sLe(x)) using monoclonal antibody FH-6. According to the histological type of lung cancer, MUSE11 positivity was observed in 90% of patients with adenocarcinoma (72/80), 51.6% of patients with squamous cell carcinoma (49/95), and 54.5% of patients with large cell carcinoma (12/22). A significant difference was detected in the expression of MUSE11 between adenocarcinoma and the two other histological types. Thus, MUSE11 appears to be a candidate for a tumor- associated marker in patients with lung adenocarcinoma. There was no relationship between the expression of MUSE11 and T factors, N factors, pathological stage, grade of differentiation, or prognosis. A significant relationship was detected between the expression of MUSE11 and that of FH-6. Earlier studies have revealed that part of sLe is associated with the MUC1 polypeptide. Our results suggested that the relationship also existed in human lung cancer specimens.

AB - We investigated the immunohistochemical expression of carcinoma- associated MUC1 in human lung cancer tissues using the monoclonal antibody MUSE11. We also investigated the expression of sialyl-Lewis x (sLe(x)) using monoclonal antibody FH-6. According to the histological type of lung cancer, MUSE11 positivity was observed in 90% of patients with adenocarcinoma (72/80), 51.6% of patients with squamous cell carcinoma (49/95), and 54.5% of patients with large cell carcinoma (12/22). A significant difference was detected in the expression of MUSE11 between adenocarcinoma and the two other histological types. Thus, MUSE11 appears to be a candidate for a tumor- associated marker in patients with lung adenocarcinoma. There was no relationship between the expression of MUSE11 and T factors, N factors, pathological stage, grade of differentiation, or prognosis. A significant relationship was detected between the expression of MUSE11 and that of FH-6. Earlier studies have revealed that part of sLe is associated with the MUC1 polypeptide. Our results suggested that the relationship also existed in human lung cancer specimens.

KW - FH-6

KW - Immunohistochemistry

KW - Lung cancer

KW - MUC1

KW - MUSE11

UR - http://www.scopus.com/inward/record.url?scp=0034029629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034029629&partnerID=8YFLogxK

U2 - 10.2482/haigan.40.85

DO - 10.2482/haigan.40.85

M3 - Article

AN - SCOPUS:0034029629

VL - 40

SP - 85

EP - 91

JO - Japanese Journal of Lung Cancer

JF - Japanese Journal of Lung Cancer

SN - 0386-9628

IS - 2

ER -